Monoclonal antibody directed against p53, binding a distinct epitope in amino acids 18-27 at the N-terminus
| Inventor | Institute |
|---|---|
| David Lane | Cancer Research UK, London Research Institute: Clare Hall Laboratories |
| Cat. #: | 153297 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Cancer types: | Other |
| Research Fields: | Apoptosis and autophagy;Cancer;Cell biology;Genetics |
| Application: | ELISA ; IHC ; IF ; IP ; WB |
| Target: | p53 |
| Reactivity: | Mouse |
| Clone: | PAb 242 |
| Host: | Mouse |
| Class: | Monoclonal |
| Primary citation: | Yewdell et al. 1986. J Virol. 59(2):444-52. PMID: 2426467. |
| Alternate name: | Antigen NY-CO-13, BCC7, Cellular tumor antigen p53, FLJ92943, LFS1, Mutant tumor protein 53, p53, p53 tumor suppressor, P53_HUMAN, Phosphoprotein p53, Tp53, Transformation related protein 53, TRP53, Tumor protein 53, Tumor protein p53, Tumor suppressor p53 |
|---|---|
| Product description: | Monoclonal antibody directed against p53, binding a distinct epitope in amino acids 18-27 at the N-terminus |
| Conjugation: | Unconjugated |
| Isotype: | IgG1 |
| Molecular weight: | 53 kDa |
| Immunogen: | SV40-transformed cell line BALB/c SVA31 E7 |
| Immunogen Uniprot ID: | P04637 |
| Myeloma used: | Sp2/0-Ag14 |
| Target background: | Anti-p53 binds p53 protein, a crucial tumour suppressor protein, implicated in over 50% of cancers. p53 is a stress-regulated transcription factor that regulates cell cycle arrest and was first identified as an SV40 large T antigen-binding protein. p53 is involved in many mechanisms of anti-cancer function and plays a role in apoptosis, genomic stability, cell cycle regulation, and inhibition of angiogenesis. p53 is known as the guardian of the genome as it functions to prevent gene mutation…. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | Store at -20° C frozen. Avoid repeated freeze / thaw cycles |
| Shipping conditions: | Dry ice |
| References: |
Sabapathy et al. 2019. J Mol Cell Biol. 11(4):317-329. PMID: 30907951. Eng et al. 2016. Protein Eng Des Sel. 29(1):11-21. PMID: 26508747. Mayelzadeh et al. 2007. Oncogene. 26(21):2955-63. PMID: 17130840. Lane et al. 1996. Oncogene. 12(11):2461-6. PMID: 8649788. Yewdell et al. 1986. J Virol. 59(2):444-52. PMID: 2426467. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151030 | Anti-Progesterone [11P14] |
Key Info
Anti-Progesterone [11P14]
|
View Tool | |||||||||||||||||||
| 151021 | Anti-CyclinB1 [V152] |
Key Info
Anti-CyclinB1 [V152]
|
View Tool | |||||||||||||||||||
| 151027 | Anti-HSVICP8 [10A3] |
Key Info
Anti-HSVICP8 [10A3]
|
View Tool | |||||||||||||||||||
| 151036 | Anti-ICAM1 [15.2] |
Key Info
Anti-ICAM1 [15.2]
|
View Tool | |||||||||||||||||||
| 151040 | Anti-CD11 & CD18 [24] |
Key Info
Anti-CD11 & CD18 [24]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.